ID 559 -
Glukoza, fruktoza
PL: Glukoza, fruktoza
EN: Glucose and fructose
Pdf: various food(s)/food constituent(s)
1.3. Udział w utrzymaniu lub osiągnięciu prawidłowej masy ciała (ID 559, 1380, 1656, 1806, 2243, 2325, 2331, 2333, 2336, 2717, 2727, 2788, 2870, 3726, 4252, 4709)
The claimed effects are “weight control; carbohydrate metabolism and insulin sensitivity”, “weight management”, “satiety/weight management/promotion of CCK release and soy foods”, “weight control”, “weight loss management, carbohydrate & lipid metabolism improvement”, “weight loss management, acid base balancer”, “weight management, thermogenesis”, “amincissement”, “slimming (cellulitis draining)”, and “weight management/satiety”. The Panel assumes that the target population is the general population.
In the context of the proposed wordings, the Panel assumes that the claimed effects refer to the maintenance or achievement of a normal body weight.
Weight management and weight control can be interpreted as contribution to the maintenance of a normal body weight. In this context, weight loss in overweight individuals without achieving a normal body weight is considered to be a beneficial physiological effect.
The Panel considers that contribution to the maintenance or achievement of a normal body weight is a beneficial physiological effect.
1.10. Ograniczenie wzrostu stężenia glukozy (glikemii) po posiłku (ID 559)
The claimed effect is “weight control; carbohydrate metabolism and insulin sensitivity”. The Panel assumes that the target population is individuals who wish to reduce their post-prandial glycaemic responses.
In the context of the proposed wordings, the Panel assumes that the claimed effect refers to the reduction of post-prandial glycaemic responses.
Postprandial glycaemia is interpreted as the elevation of blood glucose concentrations after consumption of a food and/or meal. This function is a normal physiological response which varies in magnitude and duration and which may be influenced by the chemical and physical nature of the food or meal consumed, as well as by individual factors (Venn and Green, 2007). Reducing post-prandial glycaemic responses may be beneficial to subjects with, for example, impaired glucose tolerance as long as post-prandial insulinaemic responses are not disproportionally increased. Impaired glucose tolerance is common in the general population of adults.
The Panel considers that reduction of post-prandial glycaemic responses (as long as post-prandial insulinaemic responses are not disproportionally increased) may be a beneficial physiological effect.
2.3. Udział w utrzymaniu lub osiągnięciu prawidłowej masy ciała (ID 559, 1380, 1656, 1806, 2243, 2325, 2331, 2333, 2336, 2717, 2727, 2788, 2870, 3726, 4252, 4709)
Most of the references provided in relation to these claims were narrative reviews on the potential health effects of different food(s)/food constituent(s) which did not provide any original data for the scientific substantiation of the claims, addressed the effects of food(s)/food constituent(s) other than those which are the subject of the claims, and/or investigated health outcomes (e.g. delayed gastric emptying, appetite ratings and/or subsequent food intake following a single meal or over 24 hours, energy expenditure, post-prandial blood glucose responses, insulin sensitivity and/or long-term blood glucose control, treatment of chronic venous insufficiency, bioavailability of different food constituents, on plasma concentrations of carotenoids, blood lipids and/or lipid metabolism, antioxidant properties and/or oxidative stress) other than body weight. The Panel considers that no conclusions can be drawn from these references for the scientific substantiation of the claims.
For ID 2243 and 2325, summaries of two human intervention studies on the effects of the food constituents on body weight were provided. However, the limited methodological data available in the summaries did not allow a complete scientific evaluation. The Panel considers that no conclusions can be drawn from these references for the scientific substantiation of the claims.
For ID 1656 and 2870, some internal reports identified as proprietary by the company reported on human intervention studies on the effects of the food constituents on body weight. The Panel notes that Regulation (EC) No 1924/2006 does not foresee the protection of proprietary data for health claims under Article 13.1 of the Regulation and therefore considers that these data cannot be used for the scientific substantiation of the claims.
No relevant human studies which investigated the effects of the food(s)/food constituent(s) on changes in body weight were provided in relation to any of the claims evaluated in this section.
A number of animal studies which addressed the effects of some of the food(s)/constituent(s) on body weight, and a number of animal and in vitro studies which addressed the mechanisms by which the food(s)/constituent(s) could exert the claimed effect were also provided. The Panel considers that evidence provided in animal and in vitro studies is not sufficient to predict the occurrence of an effect of the consumption of the food(s)/food constituent(s) on body weight in vivo in humans.
The Panel concludes that a cause and effect relationship has not been established between the consumption of the food(s)/food constituent(s) which are the subject of the claims evaluated in this section and contribution to the maintenance or achievement of a normal body weight.
2.10. Ograniczenie wzrostu stężenia glukozy (glikemii) po posiłku (ID 559)
The references provided in relation to this claim included narrative reviews which did not provide any original data for the scientific substantiation of the claims and studies which assessed the effects of food(s)/food constituent(s) other than the food which is the subject of the claim. The Panel considers that no conclusions can be drawn from these references for the scientific substantiation of the claim.
No human studies which investigated the effects of the food on reduction of post-prandial glycaemic responses were provided in relation to the claim evaluated in this section.
The Panel concludes that a cause and effect relationship has not been established between the consumption of the food which is the subject of the claim evaluated in this section and reduction of post-prandial glycaemic responses.
Warunki i możliwe ograniczenia stosowania oświadczenia
Fruit drink with 3g/100g of carbohydrates, 7.5g/serving, 15g/daily serving, of which sugar 2.2g/100g, 5.5g/serving, 11g/daily serving of which fructose 1.6g/100g, 4,0g/serving, 8.0g/daily serving and dextrose 0.5g/100g, 1.3g/serving, 2.5g/daily serving